The Accelerated Approval Debate: Faster FDA Drug Approvals May Mean Less Efficacy Data

Podobne zapisy

• Congress Is Likely to Approve Generic Drug User Fees: Action Should Spur Faster FDA Approvals
  od: Barlas, Stephen
  Wydane: (2012)
• Is the FDA approving drugs too fast? : Probably not—but drug recalls have sparked debate 
  od: Kleinke, J D, i wsp.
  Wydane: (1998)
• Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs
  od: Douguet, Dominique
  Wydane: (2018)
• Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste
  od: Gordy, James T., i wsp.
  Wydane: (2020)
• FDA Guidance and New Drug Approvals
  od: Walker, Scot
  Wydane: (2018)